<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00908453</url>
  </required_header>
  <id_info>
    <org_study_id>NPC-06-2</org_study_id>
    <nct_id>NCT00908453</nct_id>
  </id_info>
  <brief_title>The Study of NPC-06 - Investigation of Safety, Efficacy and Pharmacokinetics of Fosphenytoin</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nobelpharma</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nobelpharma</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is to evaluate safety, efficacy and pharmacokinetics of intravenously administered
      fosphenytoin in patients with neurosurgery, head trauma, epilepsy or status epilepticus who
      are requiring a loading dose of phenytoin.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2009</start_date>
  <completion_date type="Actual">February 2010</completion_date>
  <primary_completion_date type="Actual">February 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of adverse events</measure>
    <time_frame>8 to 12 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>frequency and nature of seizures</measure>
    <time_frame>8 to 12 days</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Epilepsy</condition>
  <arm_group>
    <arm_group_label>15mg/kg of loading dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>18mg/kg of loading dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>22.5mg/kg of loading dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>fosphenytoin</intervention_name>
    <description>15mg/kg, 18mg/kg or 22.5mg/kg of loading doses of fosphenytoin</description>
    <arm_group_label>15mg/kg of loading dose</arm_group_label>
    <arm_group_label>18mg/kg of loading dose</arm_group_label>
    <arm_group_label>22.5mg/kg of loading dose</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male or female, hospitalized patients 2 years of age or older

          -  Adult patients or guardian for pediatric patients to provide written informed consent

        Exclusion Criteria:

          -  patient with a history of hypersensitivity to hydantoins

          -  patient with hypotension, sinus bradycardia, sino-atrial block, second or third degree
             A-V block, or Adams-Stokes syndrome

          -  pregnant or nursing female patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eiji Nakagawa, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>National Center of Neurology and Psychiatry</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Center of Neurology and Psychiatry</name>
      <address>
        <city>Kodaira</city>
        <state>Tokyo</state>
        <zip>187-8551</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>May 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 21, 2009</study_first_submitted>
  <study_first_submitted_qc>May 22, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 25, 2009</study_first_posted>
  <last_update_submitted>May 21, 2010</last_update_submitted>
  <last_update_submitted_qc>May 21, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 24, 2010</last_update_posted>
  <responsible_party>
    <name_title>Nobelpharma Co., Ltd.</name_title>
    <organization>CNS group</organization>
  </responsible_party>
  <keyword>NPC-06</keyword>
  <keyword>fosphenytoin</keyword>
  <keyword>phenytoin</keyword>
  <keyword>pharmacokinetics</keyword>
  <keyword>safety</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fosphenytoin</mesh_term>
    <mesh_term>Phenytoin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

